Literature DB >> 15772852

Evidence for genetic anticipation in hereditary non-polyposis colorectal cancer.

Alexander A Westphalen1, Anna M Russell, Mauro Buser, Claudine Rey Berthod, Pierre Hutter, Martina Plasilova, Hansjakob Mueller, Karl Heinimann.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal, dominantly inherited, colorectal cancer (CRC) predisposition syndrome caused by germline mutations in DNA mismatch repair (MMR) genes, predominantly MLH1 and MSH2. Thus far, only limited data exist on the occurrence of genetic anticipation in HNPCC, i.e. the earlier age at diagnosis of CRC in successive generations. Performing nonparametric distribution-free statistical analyses, we investigated 55 parent-child pairs who had been diagnosed with CRC and who came from 21 Swiss HNPCC families with characterised MMR germline mutation (15 in MLH1 and 6 in MSH2). The overall median age at diagnosis was 43 years, with an interquartile range (IQR) of 14 and incidence ages ranging from 18 to 62 years. Descendants of HNPCC patients (median age at diagnosis 39 years, IQR=12) were found to be diagnosed with CRC significantly earlier than their parents (47 years, IQR=10), with the median of the paired age difference amounting to 8 years (IQR=15; P<0.0001). Birth cohort effects could be excluded, since the same, statistically significant, age difference was also observed in the oldest offspring birth cohort (birth year <1916; P=0.01). Genetic anticipation appeared to be more pronounced when the disease allele was transmitted through the father than through the mother (median age difference 11 vs. 4 years, respectively; both P<0.01). If confirmed in larger, ideally prospective studies, these results may have important implications for genetic counselling and clinical management of HNPCC families.

Entities:  

Mesh:

Year:  2005        PMID: 15772852     DOI: 10.1007/s00439-005-1272-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  Evidence against genetic anticipation in familial colorectal cancer.

Authors:  Y Y Tsai; G M Petersen; S V Booker; J A Bacon; S R Hamilton; F M Giardiello
Journal:  Genet Epidemiol       Date:  1997       Impact factor: 2.135

Review 2.  Genetic susceptibility to non-polyposis colorectal cancer.

Authors:  H T Lynch; A de la Chapelle
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

3.  Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction.

Authors:  T F Wang; N Kleckner; N Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Variable age of onset in hereditary nonpolyposis colorectal cancer: clinical implications.

Authors:  F H Menko; G J te Meerman; J R Sampson
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

5.  Establishment of a hereditary nonpolyposis colorectal cancer registry.

Authors:  M A Rodríguez-Bigas; P H Lee; L O'Malley; T K Weber; O Suh; G R Anderson; N J Petrelli
Journal:  Dis Colon Rectum       Date:  1996-06       Impact factor: 4.585

Review 6.  Huntington's disease and other choreas.

Authors:  N Quinn; A Schrag
Journal:  J Neurol       Date:  1998-11       Impact factor: 4.849

7.  Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation.

Authors:  Jane Green; Mary O'Driscoll; Adam Barnes; Eamonn R Maher; Peter Bridge; Keith Shields; Patrick S Parfrey
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

8.  Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.

Authors:  H F Vasen; B G Taal; G Griffioen; F M Nagengast; A Cats; F H Menko; W Oskam; J H Kleibeuker; G J Offerhaus; P M Khan
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

9.  Meiotic prophase abnormalities and metaphase cell death in MLH1-deficient mouse spermatocytes: insights into regulation of spermatogenic progress.

Authors:  Shannon Eaker; John Cobb; April Pyle; Mary Ann Handel
Journal:  Dev Biol       Date:  2002-09-01       Impact factor: 3.582

  9 in total
  16 in total

1.  The influence of parental age and gender on anticipation in familial B-cell malignancies.

Authors:  Doru T Alexandrescu; Peter H Wiernik
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome.

Authors:  Philip S Boonstra; Stephen B Gruber; Victoria M Raymond; Shu-Chen Huang; Susanne Timshel; Mef Nilbert; Bhramar Mukherjee
Journal:  Genet Epidemiol       Date:  2010-11       Impact factor: 2.135

3.  Multivariate analysis of MLH1 c.1664T>C (p.Leu555Pro) mismatch repair gene variant demonstrates its pathogenicity.

Authors:  M P Farrell; D J Hughes; M Drost; A J Wallace; R J Cummins; T A Fletcher; M A Meany; E W Kay; N de Wind; D G Power; E J Andrews; A J Green; D J Gallagher
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

4.  Fertility and apparent genetic anticipation in Lynch syndrome.

Authors:  Douglas Stupart; Aung Ko Win; Mark Jenkins; Ingrid M Winship; Paul Goldberg; Rajkumar Ramesar
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

5.  Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes.

Authors:  Christine M van Vliet; James G Dowty; Jane L van Vliet; Letitia Smith; Leeanne J Mead; Finlay A Macrae; D James B St John; Graham G Giles; Melissa C Southey; Mark A Jenkins; Gary M Velan; John L Hopper
Journal:  Hum Mutat       Date:  2011-01-25       Impact factor: 4.878

6.  BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.

Authors:  Ana Peixoto; Natália Salgueiro; Catarina Santos; Graça Varzim; Patrícia Rocha; Maria José Soares; Deolinda Pereira; Helena Rodrigues; Maria José Bento; António Fráguas; Graça Moura; Fernando Regateiro; Sérgio Castedo; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2006-07-07       Impact factor: 2.375

7.  Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Authors:  R El Tannouri; E Albuisson; P Jonveaux; E Luporsi
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

Review 8.  Potential genetic anticipation in hereditary leiomyomatosis-renal cell cancer (HLRCC).

Authors:  Mei Hua Wong; Chuen Seng Tan; Soo Chin Lee; Yvonne Yong; Aik Seng Ooi; Joanne Ngeow; Min Han Tan
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

9.  No evidence of genetic anticipation in a large family with Lynch syndrome.

Authors:  D Stupart; P Goldberg; U Algar; A Vorster; R Ramesar
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

10.  Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect.

Authors:  Rodrigo Santa Cruz Guindalini; Andrew Song; James D Fackenthal; Olufunmilayo I Olopade; Dezheng Huo
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.